About this document

Clinical Management of Weight Regain and Cardiometabolic Consequences After Discontinuation of GLP 1RA Shah Et Al.2 026 1 by marcos.rodriguez73 is a document available to read on EtoBox.

This review discusses the significant weight regain and cardiometabolic deterioration that occurs after the discontinuation of GLP-1 receptor agonists (GLP-1RAs). It highlights that approximately 60%-90% of weight lost can be regained within a year, along with a reversal of metabolic benefits, and emphasizes the need for structured follow-up and multidisciplinary management to mitigate these effects. The authors propose a framework for managing post-treatment transitions, focusing on behavioral, pharmacolog

Author

marcos.rodriguez73

Language

EN